๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Probiotics to enhance anti-infective defences in the gastrointestinal tract

โœ Scribed by Harsharnjit S Gill


Book ID
108496179
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
176 KB
Volume
17
Category
Article
ISSN
1521-6918

No coin nor oath required. For personal study only.

โœฆ Synopsis


Several clinical studies have demonstrated the therapeutic and/or prophylactic efficacy of specific probiotics against acute viral gastroenteritis and antibiotic-associated diarrhoea (including Clostridium difficile infection). Emerging evidence also suggests beneficial effects against Helicobacter pylori infection. The evidence of efficacy against traveller's diarrhoea remains, however, inconclusive. The precise mechanisms by which probiotics potentiate host gastrointestinal defences and mediate protection are not fully known. There is evidence to suggest, however, that probiotics might contribute to host defence by reinforcing non-immunological defences and stimulating both specific and non-specific host immune responses. Little is known about the relative importance of the probiotic-stimulated mechanisms in host protection. This review summarises the evidence for the anti-infective effects of probiotics and discusses the effect of orally delivered probiotics on non-immunological and immunological defence mechanisms in the host, especially in the gastrointestinal tract.


๐Ÿ“œ SIMILAR VOLUMES


Survival of the probiotic Escherichia co
โœ Thai Hoa Joeres-Nguyen-Xuan; Stephan Karl Boehm; Lars Joeres; Juergen Schulze; W ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 295 KB

Background: Mesalamine and the probiotic E. coli Nissle 1917 (EcN) are both effective agents for the treatment of ulcerative colitis. A combined therapy may have more than additive efficacy. However, mesalamine may have antimicrobial effects on EcN. ## Materials and Methods: In this prospective, r